TY - JOUR
T1 - The 2016 Assisi Think Tank Meeting on breast cancer: white paper
AU - Aristei, Cynthia
AU - Kaidar-Person, Orit
AU - Arenas, Meritxell
AU - Coles, Charlotte
AU - Offersen, Birgitte V.
AU - Bourgier, Celine
AU - Frezza, Giovanni
AU - Leonardi, Maria Cristina
AU - Valentini, Vincenzo
AU - Poortmans, Philip M. P.
PY - 2016
Y1 - 2016
N2 - Purpose: To identify weak points in daily routine use of radiation therapy (RT) for non-metastatic breast cancer patients, particularly when data are lacking or equivocal, a “think tank” of experts met in Assisi. Methods: Before the meeting, controversial issues on non-metastatic breast cancer were identified and reviewed, and clinical practice investigated by means of an online questionnaire. During the 3-day meeting, topics were discussed in-depth with attendees and potential sponsors that are involved in breast cancer treatment. Results: Three issues were identified as needing further investigation: (1) Regional lymph node treatment in early-stage breast cancer; (2) Combined post-mastectomy RT and breast reconstruction; (3) RT in patients treated with primary systemic therapy. Future research proposals included the following: (1) Participating in appropriately selected on-going clinical trials; (2) Designing new randomized controlled clinical trials and prospective population cohort studies; (3) Setting-up large database(s) to generate predictive response models and detect biomarkers for tailored loco-regional treatments. Conclusions: It is hoped that the ATTM findings, as described in the present white paper, will stimulate a new generation of radiation oncologists to focus on research in these areas, and that the white paper will become a tool for multidisciplinary groups to help them design research proposals and strategies.
AB - Purpose: To identify weak points in daily routine use of radiation therapy (RT) for non-metastatic breast cancer patients, particularly when data are lacking or equivocal, a “think tank” of experts met in Assisi. Methods: Before the meeting, controversial issues on non-metastatic breast cancer were identified and reviewed, and clinical practice investigated by means of an online questionnaire. During the 3-day meeting, topics were discussed in-depth with attendees and potential sponsors that are involved in breast cancer treatment. Results: Three issues were identified as needing further investigation: (1) Regional lymph node treatment in early-stage breast cancer; (2) Combined post-mastectomy RT and breast reconstruction; (3) RT in patients treated with primary systemic therapy. Future research proposals included the following: (1) Participating in appropriately selected on-going clinical trials; (2) Designing new randomized controlled clinical trials and prospective population cohort studies; (3) Setting-up large database(s) to generate predictive response models and detect biomarkers for tailored loco-regional treatments. Conclusions: It is hoped that the ATTM findings, as described in the present white paper, will stimulate a new generation of radiation oncologists to focus on research in these areas, and that the white paper will become a tool for multidisciplinary groups to help them design research proposals and strategies.
KW - Breast cancer
KW - Breast reconstruction
KW - Cancer Research
KW - Oncology
KW - Post-mastectomy radiation therapy
KW - Primary systemic therapy
KW - Radiation therapy
KW - Regional lymph node treatment
KW - Breast cancer
KW - Breast reconstruction
KW - Cancer Research
KW - Oncology
KW - Post-mastectomy radiation therapy
KW - Primary systemic therapy
KW - Radiation therapy
KW - Regional lymph node treatment
UR - http://hdl.handle.net/10807/92414
UR - http://www.wkap.nl/journalhome.htm/0167-6806
U2 - 10.1007/s10549-016-3998-2
DO - 10.1007/s10549-016-3998-2
M3 - Article
SN - 0167-6806
VL - 160
SP - 211
EP - 221
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
ER -